{"id":103855,"date":"2025-12-16T17:31:53","date_gmt":"2025-12-16T20:31:53","guid":{"rendered":"https:\/\/med.estrategia.com\/portal\/?p=103855"},"modified":"2026-01-06T14:26:34","modified_gmt":"2026-01-06T17:26:34","slug":"inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso","status":"publish","type":"post","link":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/","title":{"rendered":"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso"},"content":{"rendered":"<p>A divulga&ccedil;&atilde;o dos gabaritos definitivos do Enamed e do Revalida, no &uacute;ltimo dia 12 de dezembro, reacendeu o debate sobre<strong> isonomia e coer&ecirc;ncia nos processos avaliativos conduzidos pelo Instituto Nacional de Estudos e Pesquisas Educacionais An&iacute;sio Teixeira (Inep)<\/strong>. Tr&ecirc;s quest&otilde;es id&ecirc;nticas, aplicadas no mesmo dia e elaboradas pelo mesmo &oacute;rg&atilde;o, receberam tratamentos distintos nos dois exames: enquanto foram <strong>anuladas no Enamed, permaneceram v&aacute;lidas no Revalida<\/strong>, gerando questionamentos entre os candidatos.<p>Candidatos que prestaram a primeira etapa do Revalida 2025.2 relatam<strong> inseguran&ccedil;a e suposta sensa&ccedil;&atilde;o de injusti&ccedil;a<\/strong> ap&oacute;s a divulga&ccedil;&atilde;o do gabarito definitivo, sobretudo diante do impacto direto que a manuten&ccedil;&atilde;o dessas quest&otilde;es pode ter sobre a aprova&ccedil;&atilde;o no exame.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_79_2 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\"><p class=\"ez-toc-title\" style=\"cursor:inherit\">Navegue pelo conte\u00fado<\/p>\n<\/div><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Entenda-o-ocorrido\" >Entenda o ocorrido<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Questao-2-Caderno-1-%E2%80%93-Enamed\" >Quest&atilde;o 2 | Caderno 1 &ndash; Enamed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Questao-2-Caderno-1-%E2%80%93-Revalida\" >Quest&atilde;o 2 | Caderno 1 &ndash; Revalida<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Questao-10-Caderno-1-%E2%80%93-Enamed\" >Quest&atilde;o 10 | Caderno 1 &ndash; Enamed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Questao-10-Caderno-1-%E2%80%93-Revalida\" >Quest&atilde;o 10 | Caderno 1 &ndash; Revalida<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Questao-40-Caderno-1-%E2%80%93-Enamed\" >Quest&atilde;o 40 | Caderno 1 &ndash; Enamed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Questao-40-Caderno-1-%E2%80%93-Revalida\" >Quest&atilde;o 40 | Caderno 1 &ndash; Revalida<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Inscreva-se-em-nossa-newsletter\" >Inscreva-se em nossa newsletter!<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Justificativa-do-Inep\" >Justificativa do Inep<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Atualizacoes-e-atuacao-politica\" >Atualiza&ccedil;&otilde;es e atua&ccedil;&atilde;o pol&iacute;tica<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Atualizacao-%E2%80%93-questao-sobre-quimioprofilaxia-da-malaria\" >Atualiza&ccedil;&atilde;o &ndash; quest&atilde;o sobre quimioprofilaxia da mal&aacute;ria<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#Impacto-pratico-no-Revalida\" >Impacto pr&aacute;tico no Revalida<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-entenda-o-ocorrido\"><span class=\"ez-toc-section\" id=\"Entenda-o-ocorrido\"><\/span>Entenda o ocorrido<span class=\"ez-toc-section-end\"><\/span><\/h2><p>Embora o Exame Nacional de Avalia&ccedil;&atilde;o da Forma&ccedil;&atilde;o M&eacute;dica (Enamed) e o Exame Nacional de Revalida&ccedil;&atilde;o de Diplomas M&eacute;dicos (Revalida) sejam provas distintas, aplicadas no mesmo dia, <strong>ambas apresentaram algumas quest&otilde;es em comum na edi&ccedil;&atilde;o 2025 &ndash; Enamed e 2025\/2 &ndash; Revalida.<\/strong> Entre esses itens coincidentes, <strong>tr&ecirc;s quest&otilde;es foram identificadas com problemas durante o per&iacute;odo de recursos<\/strong> e acabaram anuladas pelo Inep &mdash; decis&atilde;o que, no entanto, foi aplicada apenas ao Enamed.<\/p><p>No Revalida, apesar de se tratarem das mesmas quest&otilde;es e de os problemas tamb&eacute;m terem sido apontados, os itens foram mantidos v&aacute;lidos, conforme o gabarito definitivo divulgado na &uacute;ltima sexta-feira (12). Confira:<\/p><div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/2025_gabarito_caderno_1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Gabarito Enamed 2025 | Caderno 1<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/2025_2_gabarito_caderno_1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Gabarito 1&ordf; etapa Revalida 2025.2 | Caderno 1<\/a><\/div>\n<\/div><p>As provas foram aplicadas no mesmo dia, em<strong> 19 de outubro de 2025<\/strong>, e s&atilde;o de responsabilidade do mesmo &oacute;rg&atilde;o. As quest&otilde;es em comum abordavam os seguintes temas: dist&uacute;rbio &aacute;cido-b&aacute;sico (quest&atilde;o 2), abaulamento progressivo (quest&atilde;o 10) e quimioprofilaxia (quest&atilde;o 40). Veja abaixo a reprodu&ccedil;&atilde;o dos itens:<\/p><h3 class=\"wp-block-heading\" id=\"h-questao-2-caderno-1-enamed\"><span class=\"ez-toc-section\" id=\"Questao-2-Caderno-1-%E2%80%93-Enamed\"><\/span>Quest&atilde;o 2 | Caderno 1 &ndash; Enamed<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"379\" height=\"259\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/image.png\" alt=\"\" class=\"wp-image-103858\"><\/figure><h3 class=\"wp-block-heading\" id=\"h-questao-2-caderno-1-revalida\"><span class=\"ez-toc-section\" id=\"Questao-2-Caderno-1-%E2%80%93-Revalida\"><\/span>Quest&atilde;o 2 | Caderno 1 &ndash; Revalida<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"368\" height=\"238\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/image-1.png\" alt=\"\" class=\"wp-image-103859\"><\/figure><h3 class=\"wp-block-heading\" id=\"h-questao-10-caderno-1-enamed\"><span class=\"ez-toc-section\" id=\"Questao-10-Caderno-1-%E2%80%93-Enamed\"><\/span>Quest&atilde;o 10 | Caderno 1 &ndash; Enamed<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"378\" height=\"517\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/image-2.png\" alt=\"\" class=\"wp-image-103860\"><\/figure><h3 class=\"wp-block-heading\" id=\"h-questao-10-caderno-1-revalida\"><span class=\"ez-toc-section\" id=\"Questao-10-Caderno-1-%E2%80%93-Revalida\"><\/span>Quest&atilde;o 10 | Caderno 1 &ndash; Revalida<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"383\" height=\"501\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/image-3.png\" alt=\"\" class=\"wp-image-103861\"><\/figure><h3 class=\"wp-block-heading\" id=\"h-questao-40-caderno-1-enamed\"><span class=\"ez-toc-section\" id=\"Questao-40-Caderno-1-%E2%80%93-Enamed\"><\/span>Quest&atilde;o 40 | Caderno 1 &ndash; Enamed<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"394\" height=\"234\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/image-4.png\" alt=\"\" class=\"wp-image-103862\"><\/figure><h3 class=\"wp-block-heading\" id=\"h-questao-40-caderno-1-revalida\"><span class=\"ez-toc-section\" id=\"Questao-40-Caderno-1-%E2%80%93-Revalida\"><\/span>Quest&atilde;o 40 | Caderno 1 &ndash; Revalida<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"383\" height=\"218\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/image-5.png\" alt=\"\" class=\"wp-image-103863\"><\/figure><p>Ou seja, mesmo apresentando <strong>problemas de formula&ccedil;&atilde;o<\/strong>, os itens foram <strong>cancelados apenas no Enamed<\/strong>. No Revalida, apesar de os textos serem id&ecirc;nticos, as tr&ecirc;s quest&otilde;es continuaram sendo consideradas v&aacute;lidas, o que motivou cr&iacute;ticas por parte dos candidatos, que alegam<strong> suposta viola&ccedil;&atilde;o ao princ&iacute;pio da isonomia.<\/strong><\/p><p>Ao todo, <strong>10 quest&otilde;es foram anuladas no Enamed e seis no Revalida.<\/strong> Parte dos itens anulados n&atilde;o era comum aos dois exames, uma vez que as provas tamb&eacute;m continham parte das quest&otilde;es distintas.<\/p><p>\n\n\n<div id=\"new-form\">\n\t<form id=\"forms_layout\">\n\t<input type=\"hidden\" id=\"chave_de\" name=\"chave_de\" value=\"01_EMED_LEADS_TOTAIS\" \/>\n\t\t<input type=\"hidden\" id=\"mid\" name=\"mid\" value=\"515009018\" \/>\n\t\t<input type=\"hidden\" id=\"Objetivo\" name=\"Objetivo\" value=\"Medicina\" \/>\n\t\t<input type=\"hidden\" id=\"Estado_de_Origem_do_IP\" name=\"Estado_de_Origem_do_IP\"  value=\"\" \/>\n\t\t<input type=\"hidden\" id=\"Cidade_de_Origem_do_IP\" name=\"Cidade_de_Origem_do_IP\" value=\"\" \/>\n\t\t<input type=\"hidden\" id=\"Modo_de_entrada\" name=\"Modo_de_entrada\" value=\"Portal\" \/>\n\t\t<input type=\"hidden\" id=\"Pagina_Origem\" name=\"Pagina_Origem\" value=\"\" \/>\n\n\t\t<div class=\"texto\">\n\t\t\t<h3 class=\"news\"><span class=\"ez-toc-section\" id=\"Inscreva-se-em-nossa-newsletter\"><\/span>Inscreva-se em nossa newsletter!<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\t\t\t<p>Receba not\u00edcias sobre resid\u00eancia m\u00e9dica, revalida\u00e7\u00e3o de diplomas e concursos m\u00e9dicos, al\u00e9m de materiais de estudo gratuitos e informa\u00e7\u00f5es relevantes do mundo da Medicina.<\/p>\n\t\t<\/div>\n\t\t<div class=\"campos\">\n\t\t\t<div class=\"first_name labels\">\n\t\t\t\t<input type=\"text\" class=\"input_labels\" id=\"first_name\" name=\"Nome_Completo\" placeholder=\"Nome\" required \/>\n\t\t\t<\/div>\n\t\t\t<div class=\"email labels\">\n\t\t\t\t<input type=\"email\" class=\"input_labels\" id=\"email\" name=\"Email\" placeholder=\"E-mail\" required \/>\n\t\t\t<\/div>\n\t\t\t<button type=\"submit\" class=\"button_layout\">\n\t\t\t\t<div id=\"lblBotao\">Inscreva-se<\/div>\n\t\t\t\t<span id=\"divSpiner\" class=\"loader\" role=\"status\" style=\"display: none;\"><\/span>\t\n\t\t\t<\/button>\n\t\t<\/div><!-- \/campos -->\n\t\t\n\t\t<label class=\"container_checkbox\">Voc\u00ea concorda com a nossa\n\t\t\t<a class=\"politics_privacy_ahref\" target=\"_blank\" href=\"https:\/\/gratis.estrategiaconcursos.com.br\/politica-de-privacidade\/\">Pol\u00edtica de Privacidade<\/a> e aceita receber informa\u00e7\u00f5es adicionais do Estrat\u00e9gia Educacional.\n\t\t\t<input id=\"checkbox_layout\" type=\"checkbox\" checked=\"checked\" required \/>\n\t\t\t<span class=\"checkbox\"><\/span>\n\t\t<\/label>\n\t\t<div id=\"msg\"><\/div>\n\t\t<div id=\"error\" class=\"error\">\n\t\t<\/div>\n\t<\/form>\n<\/div><!-- \/new-form -->\n\n\n\n<\/p><h2 class=\"wp-block-heading\" id=\"h-justificativa-do-inep\"><span class=\"ez-toc-section\" id=\"Justificativa-do-Inep\"><\/span>Justificativa do Inep<span class=\"ez-toc-section-end\"><\/span><\/h2><p>Em nota oficial divulgada ap&oacute;s a publica&ccedil;&atilde;o dos gabaritos definitivos, o Inep informou que algumas altera&ccedil;&otilde;es, de fato, ocorreram apenas nos gabaritos do Enamed.<\/p><p>Segundo o instituto, a anula&ccedil;&atilde;o da quest&atilde;o 10 no Enamed ocorreu em raz&atilde;o de uma<strong> diferen&ccedil;a na reda&ccedil;&atilde;o do enunciado entre os cadernos de prova<\/strong> (01 e 02 do Enamed). De acordo com a nota, a express&atilde;o &ldquo;palpa&ccedil;&atilde;o na regi&atilde;o inguinal direita&rdquo; teria sido erroneamente substitu&iacute;da por &ldquo;palpa&ccedil;&atilde;o em fossa il&iacute;aca direita&rdquo; no caderno tipo 2, o que motivou o cancelamento do item para n&atilde;o prejudicar os candidados do Enamed.<\/p><p>Contudo, nos cadernos de prova do Revalida, o item foi escrito de maneira correta. Confira como aparece <strong>a reda&ccedil;&atilde;o do enunciado nos diferentes cadernos. <\/strong>Lembrando que a quest&atilde;o 10 do caderno 1 &eacute; igual a quest&atilde;o 60 do caderno 2, em ambos os exames:<\/p><div style=\"position: relative; width: 100%; height: 0; padding-top: 100.0000%;\n padding-bottom: 0; box-shadow: 0 2px 8px 0 rgba(63,69,81,0.16); margin-top: 1.6em; margin-bottom: 0.9em; overflow: hidden;\n border-radius: 8px; will-change: transform;\">\n  <iframe loading=\"lazy\" style=\"position: absolute; width: 100%; height: 100%; top: 0; left: 0; border: none; padding: 0;margin: 0;\" src=\"https:\/\/www.canva.com\/design\/DAG7-cPnu8k\/97M2oMlmYOo-mJ_2tki1vA\/view?embed\" allowfullscreen=\"allowfullscreen\" allow=\"fullscreen\">\n  <\/iframe>\n<\/div><p>Ainda conforme o Inep, as quest&otilde;es 2 e 40 do caderno 1 tamb&eacute;m foram anuladas no Enamed <strong>&ldquo;por motivo de ajuste estat&iacute;stico &agrave; forma de c&aacute;lculo dos resultados do exame&rdquo;<\/strong>. Na mesma nota, o &oacute;rg&atilde;o esclarece que esses itens, embora correspondentes &agrave;s mesmas quest&otilde;es aplicadas no Revalida, foram mantidos v&aacute;lidos nesse exame.<\/p><p>O instituto argumenta que, apesar de os dois exames apresentarem quest&otilde;es em comum, <strong>os testes utilizam modelos distintos de corre&ccedil;&atilde;o<\/strong>. Enquanto o Enamed adota m&eacute;todos estat&iacute;sticos espec&iacute;ficos para o c&aacute;lculo dos resultados, o Revalida utiliza outro modelo, o que, segundo o Inep, justificaria a diferen&ccedil;a de tratamento dos itens anulados.<\/p><div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-2 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/12\/nota_gabarito_enamed_revalida_2025-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Confira a &iacute;ntegra da nota oficial do Inep<\/a><\/div>\n<\/div><p>O Estrat&eacute;gia MED tamb&eacute;m entrou em contato com o Inep em busca de esclarecimentos sobre os crit&eacute;rios adotados e sobre a possibilidade de extens&atilde;o da anula&ccedil;&atilde;o das quest&otilde;es ao Revalida. At&eacute; o fechamento desta mat&eacute;ria, n&atilde;o houve retorno.<\/p><h2 class=\"wp-block-heading\" id=\"h-atualizacoes-e-atuacao-politica\"><span class=\"ez-toc-section\" id=\"Atualizacoes-e-atuacao-politica\"><\/span>Atualiza&ccedil;&otilde;es e atua&ccedil;&atilde;o pol&iacute;tica<span class=\"ez-toc-section-end\"><\/span><\/h2><p>A repercuss&atilde;o do caso chegou ao Congresso Nacional. O<strong> senador Alan Rick (Uni&atilde;o-AC) <\/strong>afirmou, por meio das redes sociais, que tem recebido mensagens de candidatos do Revalida relatando a situa&ccedil;&atilde;o e que acionou formalmente o Inep para solicitar tratamento ison&ocirc;mico.<\/p><p>Segundo o parlamentar, foi <strong>encaminhado of&iacute;cio ao presidente do instituto pedindo a extens&atilde;o da anula&ccedil;&atilde;o das quest&otilde;es ao Revalida 2025.2<\/strong>, al&eacute;m da <strong>revis&atilde;o dos resultados. <\/strong>Tamb&eacute;m foi solicitada uma <strong>reuni&atilde;o com a equipe t&eacute;cnica do &oacute;rg&atilde;o para tratar do tema.<\/strong><\/p><blockquote class=\"instagram-media\" data-instgrm-captioned data-instgrm-permalink=\"https:\/\/www.instagram.com\/p\/DSThxUPkUd8\/?utm_source=ig_embed&amp;utm_campaign=loading\" data-instgrm-version=\"14\" style=\" background:#FFF; border:0; border-radius:3px; box-shadow:0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width:540px; min-width:326px; padding:0; width:99.375%; width:-webkit-calc(100% - 2px); width:calc(100% - 2px);\"><div style=\"padding:16px;\"> <a href=\"https:\/\/www.instagram.com\/p\/DSThxUPkUd8\/?utm_source=ig_embed&amp;utm_campaign=loading\" style=\" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;\" target=\"_blank\"> <div style=\" display: flex; flex-direction: row; align-items: center;\"> <div style=\"background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;\"><\/div> <div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center;\"> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;\"><\/div> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;\"><\/div><\/div><\/div><div style=\"padding: 19% 0;\"><\/div> <div style=\"display:block; height:50px; margin:0 auto 12px; width:50px;\"><svg width=\"50px\" height=\"50px\" viewbox=\"0 0 60 60\" version=\"1.1\" xmlns=\"https:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"https:\/\/www.w3.org\/1999\/xlink\"><g stroke=\"none\" stroke-width=\"1\" fill=\"none\" fill-rule=\"evenodd\"><g transform=\"translate(-511.000000, -20.000000)\" fill=\"#000000\"><g><path d=\"M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631\"><\/path><\/g><\/g><\/g><\/svg><\/div><div style=\"padding-top: 8px;\"> <div style=\" color:#3897f0; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:550; line-height:18px;\">Ver essa foto no Instagram<\/div><\/div><div style=\"padding: 12.5% 0;\"><\/div> <div style=\"display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;\"><div> <div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);\"><\/div> <div style=\"background-color: #F4F4F4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;\"><\/div> <div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);\"><\/div><\/div><div style=\"margin-left: 8px;\"> <div style=\" background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;\"><\/div> <div style=\" width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg)\"><\/div><\/div><div style=\"margin-left: auto;\"> <div style=\" width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);\"><\/div> <div style=\" background-color: #F4F4F4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);\"><\/div> <div style=\" width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);\"><\/div><\/div><\/div> <div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center; margin-bottom: 24px;\"> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 224px;\"><\/div> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 144px;\"><\/div><\/div><\/a><p style=\" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; line-height:17px; margin-bottom:0; margin-top:8px; overflow:hidden; padding:8px 0 7px; text-align:center; text-overflow:ellipsis; white-space:nowrap;\"><a href=\"https:\/\/www.instagram.com\/p\/DSThxUPkUd8\/?utm_source=ig_embed&amp;utm_campaign=loading\" style=\" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:normal; line-height:17px; text-decoration:none;\" target=\"_blank\">Um post compartilhado por Alan Rick (@alanrickm)<\/a><\/p><\/div><\/blockquote><script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><h3 class=\"wp-block-heading\" id=\"h-atualizacao-questao-sobre-quimioprofilaxia-da-malaria\"><span class=\"ez-toc-section\" id=\"Atualizacao-%E2%80%93-questao-sobre-quimioprofilaxia-da-malaria\"><\/span>Atualiza&ccedil;&atilde;o &ndash; quest&atilde;o sobre quimioprofilaxia da mal&aacute;ria<span class=\"ez-toc-section-end\"><\/span><\/h3><p>Em resposta a um pedido de acesso &agrave; informa&ccedil;&atilde;o feito por uma candidata do Revalida, <strong>o Minist&eacute;rio da Sa&uacute;de afirmou que n&atilde;o recomenda o uso rotineiro de quimioprofilaxia contra a mal&aacute;ria no Brasil<\/strong>, inclusive para profissionais que atuam em &aacute;reas end&ecirc;micas, como a regi&atilde;o amaz&ocirc;nica. O esclarecimento foi prestado pela Coordena&ccedil;&atilde;o-Geral de Elimina&ccedil;&atilde;o da Mal&aacute;ria, vinculada &agrave; Secretaria de Vigil&acirc;ncia em Sa&uacute;de e Ambiente.<\/p><p>Segundo o &oacute;rg&atilde;o, o pa&iacute;s conta com uma rede estruturada de diagn&oacute;stico e tratamento da mal&aacute;ria, especialmente na Amaz&ocirc;nia, com oferta gratuita de testes e medicamentos pelo Sistema &Uacute;nico de Sa&uacute;de (SUS). A diretriz &eacute; que, <strong>diante de suspeita cl&iacute;nica, o atendimento ocorra nos servi&ccedil;os de sa&uacute;de locais, com confirma&ccedil;&atilde;o diagn&oacute;stica e in&iacute;cio oportuno do tratamento, quando indicado.<\/strong><\/p><p>O Minist&eacute;rio destaca ainda que <strong>a quimioprofilaxia &eacute; indicada apenas em situa&ccedil;&otilde;es muito espec&iacute;ficas,<\/strong> ap&oacute;s avalia&ccedil;&atilde;o criteriosa do risco de transmiss&atilde;o, sobretudo no contexto de viajantes internacionais. <strong>No cen&aacute;rio brasileiro, essa estrat&eacute;gia n&atilde;o &eacute; recomendada, inclusive porque h&aacute; predom&iacute;nio de infec&ccedil;&otilde;es por <em>Plasmodium vivax<\/em><\/strong>, esp&eacute;cie para a qual<strong> a efic&aacute;cia da quimioprofilaxia &eacute; considerada baixa<\/strong>, conforme evid&ecirc;ncias cient&iacute;ficas.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&ldquo;No caso dos profissionais do Programa Mais M&eacute;dicos, n&atilde;o h&aacute; indica&ccedil;&atilde;o de quimioprofilaxia, pois, diante da suspeita de mal&aacute;ria, esses profissionais podem procurar os servi&ccedil;os de sa&uacute;de locais para realiza&ccedil;&atilde;o do diagn&oacute;stico, seja por meio do Teste de Diagn&oacute;stico R&aacute;pido (TDR) ou do exame de gota espessa, caso confirmada a infec&ccedil;&atilde;o por Plasmodium, iniciar o tratamento adequado&rdquo;<\/p>\n\n\n\n<p>Coordenador-Geral de Elimina&ccedil;&atilde;o da Mal&aacute;ria, via Solicita&ccedil;&atilde;o de Acesso &agrave; Informa&ccedil;&atilde;o<\/p>\n<\/blockquote><p>Como medidas preventivas, o &oacute;rg&atilde;o orienta o uso de repelentes, roupas que cubram a maior parte do corpo e mosquiteiros impregnados com inseticidas de longa dura&ccedil;&atilde;o, al&eacute;m da considera&ccedil;&atilde;o das &aacute;reas espec&iacute;ficas de transmiss&atilde;o em cada munic&iacute;pio. <strong>As diretrizes oficiais est&atilde;o descritas no Guia de Tratamento da Mal&aacute;ria no Brasil, publicado pelo Minist&eacute;rio da Sa&uacute;de<\/strong>. Com base nessa resposta oficial, a interpreta&ccedil;&atilde;o &eacute; de que <strong>a orienta&ccedil;&atilde;o apresentada na quest&atilde;o 40 do caderno 1 n&atilde;o procede, o que refor&ccedil;aria o pedido de anula&ccedil;&atilde;o do item no Revalida.<\/strong><\/p><blockquote class=\"instagram-media\" data-instgrm-captioned data-instgrm-permalink=\"https:\/\/www.instagram.com\/reel\/DTLO1JVDRMk\/?utm_source=ig_embed&amp;utm_campaign=loading\" data-instgrm-version=\"14\" style=\" background:#FFF; border:0; border-radius:3px; box-shadow:0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width:540px; min-width:326px; padding:0; width:99.375%; width:-webkit-calc(100% - 2px); width:calc(100% - 2px);\"><div style=\"padding:16px;\"> <a href=\"https:\/\/www.instagram.com\/reel\/DTLO1JVDRMk\/?utm_source=ig_embed&amp;utm_campaign=loading\" style=\" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;\" target=\"_blank\"> <div style=\" display: flex; flex-direction: row; align-items: center;\"> <div style=\"background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;\"><\/div> <div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center;\"> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;\"><\/div> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;\"><\/div><\/div><\/div><div style=\"padding: 19% 0;\"><\/div> <div style=\"display:block; height:50px; margin:0 auto 12px; width:50px;\"><svg width=\"50px\" height=\"50px\" viewbox=\"0 0 60 60\" version=\"1.1\" xmlns=\"https:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"https:\/\/www.w3.org\/1999\/xlink\"><g stroke=\"none\" stroke-width=\"1\" fill=\"none\" fill-rule=\"evenodd\"><g transform=\"translate(-511.000000, -20.000000)\" fill=\"#000000\"><g><path d=\"M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631\"><\/path><\/g><\/g><\/g><\/svg><\/div><div style=\"padding-top: 8px;\"> <div style=\" color:#3897f0; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:550; line-height:18px;\">Ver essa foto no Instagram<\/div><\/div><div style=\"padding: 12.5% 0;\"><\/div> <div style=\"display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;\"><div> <div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);\"><\/div> <div style=\"background-color: #F4F4F4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;\"><\/div> <div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);\"><\/div><\/div><div style=\"margin-left: 8px;\"> <div style=\" background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;\"><\/div> <div style=\" width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg)\"><\/div><\/div><div style=\"margin-left: auto;\"> <div style=\" width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);\"><\/div> <div style=\" background-color: #F4F4F4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);\"><\/div> <div style=\" width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);\"><\/div><\/div><\/div> <div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center; margin-bottom: 24px;\"> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 224px;\"><\/div> <div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 144px;\"><\/div><\/div><\/a><p style=\" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; line-height:17px; margin-bottom:0; margin-top:8px; overflow:hidden; padding:8px 0 7px; text-align:center; text-overflow:ellipsis; white-space:nowrap;\"><a href=\"https:\/\/www.instagram.com\/reel\/DTLO1JVDRMk\/?utm_source=ig_embed&amp;utm_campaign=loading\" style=\" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:normal; line-height:17px; text-decoration:none;\" target=\"_blank\">Um post compartilhado por B&aacute;rbara D&rsquo;Alegria | CRM: 52-98490-6 | RQE: 32341 (@prof.barbaradalegria)<\/a><\/p><\/div><\/blockquote><script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><h2 class=\"wp-block-heading\" id=\"h-impacto-pratico-no-revalida\"><span class=\"ez-toc-section\" id=\"Impacto-pratico-no-Revalida\"><\/span>Impacto pr&aacute;tico no Revalida<span class=\"ez-toc-section-end\"><\/span><\/h2><p>A nota de corte da primeira etapa do Revalida INEP 2025.2 foi fixada em 61 pontos. Nesse contexto, a manuten&ccedil;&atilde;o de tr&ecirc;s quest&otilde;es com problemas de formula&ccedil;&atilde;o pode estar impedindo candidatos de atingirem a pontua&ccedil;&atilde;o m&iacute;nima necess&aacute;ria para aprova&ccedil;&atilde;o.<\/p><p>Em avalia&ccedil;&otilde;es como o Revalida, a<strong> anula&ccedil;&atilde;o de quest&otilde;es gera pontua&ccedil;&atilde;o para todos os participantes<\/strong>. Assim, a decis&atilde;o de manter os itens v&aacute;lidos pode impactar diretamente o desempenho final, influenciando resultados de aprova&ccedil;&atilde;o ou reprova&ccedil;&atilde;o de um n&uacute;mero significativo de candidatos.<\/p><p>Diante do cen&aacute;rio,<strong> candidatos j&aacute; avaliam a ado&ccedil;&atilde;o de medidas judiciais cab&iacute;veis.<\/strong><\/p><p>Apesar da repercuss&atilde;o crescente, do questionamento p&uacute;blico e da mobiliza&ccedil;&atilde;o pol&iacute;tica, <strong>o Inep ainda n&atilde;o se manifestou diretamente sobre a possibilidade de revis&atilde;o da decis&atilde;o<\/strong> ou de aplica&ccedil;&atilde;o de<strong> crit&eacute;rios ison&ocirc;micos entre os dois exames<\/strong>. O sil&ecirc;ncio do &oacute;rg&atilde;o refor&ccedil;a a insatisfa&ccedil;&atilde;o dos candidatos e amplia a press&atilde;o por esclarecimentos e eventual retifica&ccedil;&atilde;o.<\/p><p>Para acompanhar poss&iacute;veis mudan&ccedil;as em primeira m&atilde;o, continue acompanhando o Portal de Not&iacute;cias do Estrat&eacute;gia MED. Aqui, voc&ecirc; encontrar&aacute; informa&ccedil;&otilde;es atualizadas sobre resid&ecirc;ncias, carreira m&eacute;dica e muito mais.<\/p><p>\n\n\n\n<a id=\"cta\" class=\"cta-imagem\" href=\"https:\/\/med.estrategia.com\/cursos\/gratuitos\/\" target=\"blank\">\n                <img decoding=\"async\" width=\"100%\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/08\/cursos_gratuitos.jpg\" alt=\"cursos gratuitos\" title=\"cursos_gratuitos\">\n        <\/a>\n<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"A divulga&ccedil;&atilde;o dos gabaritos definitivos do Enamed e do Revalida, no &uacute;ltimo dia 12 de dezembro, reacendeu o&hellip;\n","protected":false},"author":22,"featured_media":59405,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wl_entities_gutenberg":"","footnotes":""},"categories":[300],"tags":[],"wl_entity_type":[199],"class_list":{"0":"post-103855","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-noticias","8":"wl_entity_type-article"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso<\/title>\n<meta name=\"description\" content=\"Entenda o caso que fez o Inep anular quest\u00f5es no Enamed, mas itens id\u00eanticos seguiram v\u00e1lidos no Revalida. Candidatos cobram is\u00f4nomia do \u00f3rg\u00e3o.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso\" \/>\n<meta property=\"og:description\" content=\"Entenda o caso que fez o Inep anular quest\u00f5es no Enamed, mas itens id\u00eanticos seguiram v\u00e1lidos no Revalida. Candidatos cobram is\u00f4nomia do \u00f3rg\u00e3o.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/\" \/>\n<meta property=\"og:site_name\" content=\"Estrat\u00e9gia MED\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/estrategiamed1\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-16T20:31:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-06T17:26:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Erika Coelho\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:site\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Erika Coelho\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/\",\"name\":\"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso\",\"isPartOf\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg\",\"datePublished\":\"2025-12-16T20:31:53+00:00\",\"dateModified\":\"2026-01-06T17:26:34+00:00\",\"author\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/8e7c9b2f53f2eede3b8880ad86ff20a3\"},\"description\":\"Entenda o caso que fez o Inep anular quest\u00f5es no Enamed, mas itens id\u00eanticos seguiram v\u00e1lidos no Revalida. Candidatos cobram is\u00f4nomia do \u00f3rg\u00e3o.\",\"breadcrumb\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#primaryimage\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg\",\"width\":1920,\"height\":1280,\"caption\":\"Foto: Marcelo Camargo\/Ag\u00eancia Brasil\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/med.estrategia.com\/portal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/med.estrategia.com\/portal\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\",\"url\":\"https:\/\/med.estrategia.com\/portal\/\",\"name\":\"Estrat\u00e9gia MED\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/8e7c9b2f53f2eede3b8880ad86ff20a3\",\"name\":\"Erika Coelho\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8ef9ff2e2fa53829c640cca8d1a45178?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8ef9ff2e2fa53829c640cca8d1a45178?s=96&d=mm&r=g\",\"caption\":\"Erika Coelho\"},\"description\":\"Jornalista pela Universidade Presbiteriana Mackenzie, escrevo sobre educa\u00e7\u00e3o, sa\u00fade e pol\u00edticas p\u00fablicas\",\"url\":\"https:\/\/med.estrategia.com\/portal\/author\/erika\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso","description":"Entenda o caso que fez o Inep anular quest\u00f5es no Enamed, mas itens id\u00eanticos seguiram v\u00e1lidos no Revalida. Candidatos cobram is\u00f4nomia do \u00f3rg\u00e3o.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/","og_locale":"pt_BR","og_type":"article","og_title":"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso","og_description":"Entenda o caso que fez o Inep anular quest\u00f5es no Enamed, mas itens id\u00eanticos seguiram v\u00e1lidos no Revalida. Candidatos cobram is\u00f4nomia do \u00f3rg\u00e3o.","og_url":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/","og_site_name":"Estrat\u00e9gia MED","article_publisher":"https:\/\/www.facebook.com\/estrategiamed1","article_published_time":"2025-12-16T20:31:53+00:00","article_modified_time":"2026-01-06T17:26:34+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg","type":"image\/jpeg"}],"author":"Erika Coelho","twitter_card":"summary_large_image","twitter_creator":"@estrategiamed_","twitter_site":"@estrategiamed_","twitter_misc":{"Escrito por":"Erika Coelho","Est. tempo de leitura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/","url":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/","name":"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso","isPartOf":{"@id":"https:\/\/med.estrategia.com\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#primaryimage"},"image":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#primaryimage"},"thumbnailUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg","datePublished":"2025-12-16T20:31:53+00:00","dateModified":"2026-01-06T17:26:34+00:00","author":{"@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/8e7c9b2f53f2eede3b8880ad86ff20a3"},"description":"Entenda o caso que fez o Inep anular quest\u00f5es no Enamed, mas itens id\u00eanticos seguiram v\u00e1lidos no Revalida. Candidatos cobram is\u00f4nomia do \u00f3rg\u00e3o.","breadcrumb":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#primaryimage","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/inep_mcamgo_abr_191120211818-5.jpg","width":1920,"height":1280,"caption":"Foto: Marcelo Camargo\/Ag\u00eancia Brasil"},{"@type":"BreadcrumbList","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.estrategia.com\/portal\/"},{"@type":"ListItem","position":2,"name":"Not\u00edcias","item":"https:\/\/med.estrategia.com\/portal\/noticias\/"},{"@type":"ListItem","position":3,"name":"Inep anula quest\u00f5es no Enamed, mas mant\u00e9m itens id\u00eanticos v\u00e1lidos no Revalida; entenda o caso"}]},{"@type":"WebSite","@id":"https:\/\/med.estrategia.com\/portal\/#website","url":"https:\/\/med.estrategia.com\/portal\/","name":"Estrat\u00e9gia MED","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/8e7c9b2f53f2eede3b8880ad86ff20a3","name":"Erika Coelho","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8ef9ff2e2fa53829c640cca8d1a45178?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8ef9ff2e2fa53829c640cca8d1a45178?s=96&d=mm&r=g","caption":"Erika Coelho"},"description":"Jornalista pela Universidade Presbiteriana Mackenzie, escrevo sobre educa\u00e7\u00e3o, sa\u00fade e pol\u00edticas p\u00fablicas","url":"https:\/\/med.estrategia.com\/portal\/author\/erika\/"}]}},"_wl_alt_label":[],"wl:entity_url":"\/post\/inep-anula-questoes-no-enamed-mas-mantem-itens-identicos-validos-no-revalida-entenda-o-caso-103855","_links":{"self":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/103855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/comments?post=103855"}],"version-history":[{"count":8,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/103855\/revisions"}],"predecessor-version":[{"id":104794,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/103855\/revisions\/104794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media\/59405"}],"wp:attachment":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media?parent=103855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/categories?post=103855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/tags?post=103855"},{"taxonomy":"wl_entity_type","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/wl_entity_type?post=103855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}